Stay updated on Eptinezumab Efficacy in Refractory Migraine Clinical Trial

Sign up to get notified when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and FAQs about the terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition.
    Difference
    0.6%
    Check dated 2026-10-25T16:12:50.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:06:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T21:52:33.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history, and the prior revision v3.6.6 was removed, updating the page's version history.
    Difference
    0.1%
    Check dated 2026-09-20T20:49:48.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    New revision v3.6.6 was added to the study history. The previous v3.6.5 entry was removed, updating the page's version history.
    Difference
    0.1%
    Check dated 2026-08-30T21:45:24.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Record History now includes new sections and controls (Compare, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Study Status) and lists dated version entries. This change enhances the ability to review and compare how the study record has evolved over time by exposing key data sections in the history view.
    Difference
    21%
    Check dated 2026-08-16T15:31:48.000Z thumbnail image

Stay in the know with updates to Eptinezumab Efficacy in Refractory Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.